South Beach Symposium Recap: Day 3
Catch up on coverage from the third day of South Beach Symposium.
Benzene Contamination and Boxed Warning Myths With Christopher Bunick, MD, PhD
SBS 2023 planning committee member, Christopher Bunick, MD, PhD, shares highlights from a few key sessions.
Acne and Rosace Updates at SBS 2023
Hilary Baldwin, MD, shares treatment updates and recommendations for acne and rosacea at South Beach Symposium.
Karan Lal, DO, FAAD, Discusses Highlights from SBS and MOPDS
The Masters of Pediatric Dermatology Symposium at SBS 2023 covered current trends and updates in pediatric dermatology.
New Innovations in Genomics
Aaron Farberg, MD, FAAD, discussed updates and applications of genomics in dermatology at South Beach Symposium.
What’s Trending in Body Rejuvenation?
Suneel Chilukuri, MD, presented top trending topics in body rejuvenation at SBS 2023.
New Positive Phase 3 Data of Delgocitinib for Chronic Hand Eczema
Chronic hand eczema can have a significant negative impact on quality of life.
South Beach Symposium Recap: Day 2
Catch up on coverage from the second day of South Beach Symposium.
Hyperpigmentation With Suneel Chilukuri, MD
Chilukuri shares pearls from his hyperpigmentation session at SBS 2023.
Healthy Skin Barrier for Xerosis in Mature Skin
The development of xerosis in mature skin was analyzed in a poster presentation from SBS 2023.
Aesthetic Procedures for LGBTQ+ Patients
Ronda Farah, MD, gave an in-depth overview of aesthetic procedures to understand for LGBTQ+ patients at SBS 2023.
Artificial Intelligence and Skin Cancer
Laura Ferris, MD, PhD, discusses the future landscape of artificial intelligence and skin cancer detection at SBS 2023.
Glynis Ablon, MD, FAAD, Discusses Filler Complications and Exosomes
Ablon’s sessions at SBS 2023 covered filler complications and the future of exosomes.
South Beach Symposium Recap: Day 1
Catch up on coverage from the first day of South Beach Symposium.
Increasing Rates of Melanoma and What to Look For
David Goldberg, MD, JD, explores the increasing rates of melanoma in the US and how to manage melanoma subtypes at SBS 2023.
Psychosocial and Social Media Impact on Adolescent Skin Disease and Mental Health
A poster presentation from SBS 2023 analyzed the relationship between dermatology and social media.
Visiting the Sunshine State: What to do While Attending SBS
Discover fun activities to explore while attending South Beach Symposium 2023.
Aaron Farberg, MD, FAAD, Discusses Hedgehog Inhibitors at SBS
Farberg shares key pearls from his session on when to use hedgehog inhibitors at South Beach Symposium 2023.
What to Expect at the 2023 South Beach Symposium Meeting
The 2023 South Beach Symposium meeting begins today in Miami Beach, Florida.
The Mainstream Patient: February 7
This week's edition of the Mainstream Patient features stories about recommended razors for keratosis pilaris, dermatologist-recommended retinol serums, how to patch test skin care products, and more.
HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
Newly released safety and efficacy data on Novartis’ secukinumab for hidradenitis suppurativa is published in The Lancet.
The Weekly Roundup: January 30-February 3
ICYMI, this week we had stories about adalimumab biosimilars, an expanded Banana Boat Hair & Scalp Sunscreen recall, what's trending in skin care for January 2023, and more.
The Mainstream Patient: February 2
This week's edition of the Mainstream Patient features stories about sensitive skin around the eyes, health risks of sharing razors, keratin shampoos for stronger hair, and more.
Celebrating Patients With Skin of Color
Explore a collection of the best skin tips for patients with skin of color.
Discover Dermatology Times: January 2023
Learn more about what in-depth topics were covered in the January 2023 issue of Dermatology Times.
What's Trending in Skin Care: January 2023
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of January.
First Adalimumab Biosimilar, Adalimumab-atto, Available in the US
Christopher Bunick, MD, PhD, and Raj Chovatiya, MD, PhD, discuss the benefits of adalimumab-atto and the future of additional biosimilars in 2023.
Spesolimab Shows Significant Prevention of GPP Flares up to 48 Weeks
Preventing generalized pustular psoriasis may be possible based on recent data.
Physician Assistant Ranked as 4th Best Job in 2023
The need for physician assistants is expected to increase.
The Weekly Roundup: January 16-20
ICYMI, this week we had stories about conference coverage from Winter Clinical Hawaii, generalized pustular psoriasis management, nutritional supplements for hair loss, and more.